Berlin, December 7, 2022-Current recommendations on the supply bottleneck of nanoparticle albumin-bound paclitaxel (nab-paclitaxel)

被引：0
作者：
不详
机构：
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 02期
关键词：
PANCREATIC-CANCER; CHEMOTHERAPY; GEMCITABINE; FOLFIRINOX; SURVIVAL;
D O I：
10.1055/a-1998-7964
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页码：158 / 159
页数：2
相关论文
共 50 条
[41]   A phase 2 study of nanoparticle albumin-bound paclitaxel plus nedaplatin for patients with advanced, recurrent, or metastatic cervical carcinoma [J].
Li, Yifan ;
Zeng, Jing ;
Huang, Manni ;
An, Jusheng ;
Bai, Ping ;
Wu, Lingying ;
Zhang, Rong .
CANCER, 2017, 123 (03) :420-425
[42]   Impact of ABCB1 single-nucleotide variants on early, extremely severe neutropenia induced by paclitaxel/nanoparticle albumin-bound paclitaxel in patients with gastric cancer [J].
Maeda, Akimitsu ;
Matsuo, Keitaro ;
Ando, Hitoshi ;
Morishige, Jun-ichi ;
Muro, Kei ;
Uchida, Kosaku ;
Tajika, Masahiro .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, :1216-1222
[43]   Higher rate of skin rash in a phase II trial with weekly nanoparticle albumin-bound paclitaxel and cisplatin combination in Chinese breast cancer patients [J].
Tang, Li Chen ;
Wang, Bi Yun ;
Sun, Si ;
Zhang, Jian ;
Jia, Zhen ;
Lu, Yun Hua ;
Di, Geng Hong ;
Shao, Zhi Ming ;
Hu, Xi Chun .
BMC CANCER, 2013, 13
[44]   Clinical experience with nanoparticle albumin-bound paclitaxel, a novel taxane anticancer agent, and management of adverse events in females with breast cancer [J].
Takashima, Seiki ;
Kiyoto, Sachiko ;
Takahashi, Mina ;
Hara, Fumikata ;
Aogi, Kenjiro ;
Ohsumi, Shozo ;
Mukai, Ryoko ;
Fujita, Yoriko .
ONCOLOGY LETTERS, 2015, 9 (04) :1822-1826
[45]   Nanoparticle Albumin-Bound Paclitaxel- and/or Gemcitabine-Induced Scleroderma Accompanied by Acanthosis Nigricans-Like Skin Changes [J].
Motegi, Sei-ichiro ;
Ishikawa, Mai ;
Sekiguchi, Akiko ;
Ishikawa, Osamu .
CASE REPORTS IN DERMATOLOGY, 2019, 11 (03) :273-277
[46]   Safety and Efficacy of Low-dose Nanoparticle Albumin-bound Paclitaxel for HER2-negative Metastatic Breast Cancer [J].
Takashima, Tsutomu ;
Kawajiri, Hidemi ;
Nishimori, Takeo ;
Tei, Seika ;
Nishimura, Shigehiko ;
Yamagata, Shigehito ;
Tokunaga, Shinya ;
Mizuyama, Yoko ;
Sunami, Takeshi ;
Tezuka, Kenji ;
Ikeda, Katsumi ;
Ogawa, Yoshinari ;
Kashiwagi, Shinichiro ;
Noda, Satoru ;
Onoda, Naoyoshi ;
Ishikawa, Tetsuro ;
Kudoh, Shinzoh ;
Takada, Minoru ;
Hirakawa, Kosei ;
Ohira, Masaichi .
ANTICANCER RESEARCH, 2018, 38 (01) :379-383
[47]   Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: a retrospective study [J].
Tian, Zhichao ;
Dong, Shuping ;
Yang, Yang ;
Gao, Shilei ;
Yang, Yonghao ;
Yang, Jinpo ;
Zhang, Peng ;
Wang, Xin ;
Yao, Weitao .
BMC CANCER, 2022, 22 (01)
[48]   Nanoparticle albumin-bound paclitaxel/liposomal-encapsulated doxorubicin in HER2-negative metastatic breast cancer patients [J].
Fabi, Alessandra ;
Ferretti, Gianluigi ;
Malaguti, Paola ;
Gasparro, Simona ;
Nistico, Cecilia ;
Arpino, Grazia ;
Papaldo, Paola ;
Russillo, Michelangelo ;
Catania, Giovanna ;
Schettini, Francesco ;
Giannarelli, Diana ;
Cognetti, Francesco .
FUTURE ONCOLOGY, 2020, 16 (22) :1629-1637
[49]   Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance) [J].
Rugo, Hope S. ;
Barry, William T. ;
Moreno-Aspitia, Alvaro ;
Lyss, Alan P. ;
Cirrincione, Constance ;
Leung, Eleanor ;
Mayer, Erica L. ;
Naughton, Michael ;
Toppmeyer, Deborah ;
Carey, Lisa A. ;
Perez, Edith A. ;
Hudis, Clifford ;
Winer, Eric P. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (21) :2361-U57
[50]   Weekly nanoparticle albumin-bound paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma [J].
Wang, Hai-ying ;
Yao, Zhi-hua ;
Tang, Hong ;
Zhao, Yan ;
Zhang, Xiao-san ;
Yao, Shu-na ;
Yang, Shu-jun ;
Liu, Yan-yan .
ONCOTARGETS AND THERAPY, 2016, 9 :5663-5669
12345